Diabetes Care Drugs Market 2028 by Product, Distribution Channel and Geography | The Insight Partners

Diabetes Care Drugs Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product (Injectable, Oral Antidiabetic Drugs); Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies) and Geography

Report Code: TIPRE00008471 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Diabetes Care Drugs are drugs used by diabetics to maintain the blood glucose levels to restore the blood glucose metabolism to a normal state.

MARKET DYNAMICS

The factors that drive the global diabetes care drugs market include rise in geriatric population and increase in prevalence of diabetes worldwide. Additionally, rising awareness regarding diabetes care, growing prevalence of obesity will further spur the market growth. However, side effects of diabetic drugs and stringent approval process for drugs impede the market growth.

MARKET SCOPE

The "Global Diabetes Care Drugs Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Diabetes Care Drugs Market with detailed market segmentation by product, distribution channel and geography. The Global Diabetes Care Drugs Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Diabetes Care Drugs Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Global Diabetes Care Drugs Market is segmented on the basis of product, distribution channel. On the basis of product, the market is segmented into injectable and oral antidiabetic drugs (OAD). The injectable segment is further segmented into insulin, glucagon-like peptide-1 (GLP-1) receptor agonists/incretin mimetics, and amylin analogue/amylinomimetic drugs. The oral antidiabetic drugs (OAD) is further sub segmented into biguanides, sulfonylureas, thiazolidinediones, alpha-glucosidase inhibitors, dipeptidyl peptidase iv (dpp-4) inhibitors/gliptins, meglitinides, sodium-glucose cotransporter-2 (sglt2) inhibitors/gliflozins. Based on distribution channel the market is segment into, online pharmacies, hospital pharmacies and retail pharmacies.
?


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Diabetes Care Drugs Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Diabetes Care Drugs Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Diabetes Care Drugs market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Diabetes Care Drugs Market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Diabetes Care Drugs Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Diabetes Care Drugs Market are anticipated to lucrative growth opportunities in the future with the rising demand for Diabetes Care Drugs Market in the global market. Below mentioned is the list of few companies engaged in the Diabetes Care Drugs Market.

The report also includes the profiles of key Diabetes Care Drugs Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- AstraZeneca plc.
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
- Novo Nordisk
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetes Care Drugs Market - By Product
1.3.2 Diabetes Care Drugs Market - By Distribution Channel
1.3.3 Diabetes Care Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIABETES CARE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETES CARE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DIABETES CARE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETES CARE DRUGS - GLOBAL MARKET OVERVIEW
6.2. DIABETES CARE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETES CARE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INJECTABLE
7.3.1. Overview
7.3.2. Injectable Market Forecast and Analysis
7.3.3. Insulin Market
7.3.3.1. Overview
7.3.3.2. Insulin Market Forecast and Analysis
7.3.4. Glucagon-like Peptide-1 (GLP-1) Receptor Agonists/Incretin Mimetics Market
7.3.4.1. Overview
7.3.4.2. Glucagon-like Peptide-1 (GLP-1) Receptor Agonists/Incretin Mimetics Market Forecast and Analysis
7.3.5. Amylin Analogue/Amylinomimetic Drugs Market
7.3.5.1. Overview
7.3.5.2. Amylin Analogue/Amylinomimetic Drugs Market Forecast and Analysis
7.4. ORAL ANTIDIABETIC DRUGS
7.4.1. Overview
7.4.2. Oral Antidiabetic Drugs Market Forecast and Analysis
7.4.3. Biguanides Market
7.4.3.1. Overview
7.4.3.2. Biguanides Market Forecast and Analysis
7.4.4. Sulfonylureas Market
7.4.4.1. Overview
7.4.4.2. Sulfonylureas Market Forecast and Analysis
7.4.5. Thiazolidinediones Market
7.4.5.1. Overview
7.4.5.2. Thiazolidinediones Market Forecast and Analysis
7.4.6. Alpha-Glucosidase Inhibitors Market
7.4.6.1. Overview
7.4.6.2. Alpha-Glucosidase Inhibitors Market Forecast and Analysis
7.4.7. Dipeptidyl Peptidase Iv (Dpp-4) Inhibitors/Gliptins Market
7.4.7.1. Overview
7.4.7.2. Dipeptidyl Peptidase Iv (Dpp-4) Inhibitors/Gliptins Market Forecast and Analysis
7.4.8. Meglitinides Market
7.4.8.1. Overview
7.4.8.2. Meglitinides Market Forecast and Analysis
7.4.9. Sodium-Glucose Cotransporter-2 (Sglt2) Inhibitors/Gliflozins Market
7.4.9.1. Overview
7.4.9.2. Sodium-Glucose Cotransporter-2 (Sglt2) Inhibitors/Gliflozins Market Forecast and Analysis
8. DIABETES CARE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. ONLINE PHARMACIES
8.3.1. Overview
8.3.2. Online Pharmacies Market Forecast and Analysis
8.4. HOSPITAL PHARMACIES
8.4.1. Overview
8.4.2. Hospital Pharmacies Market Forecast and Analysis
8.5. RETAIL PHARMACIES
8.5.1. Overview
8.5.2. Retail Pharmacies Market Forecast and Analysis
9. DIABETES CARE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Diabetes Care Drugs Market Overview
9.1.2 North America Diabetes Care Drugs Market Forecasts and Analysis
9.1.3 North America Diabetes Care Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Diabetes Care Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Diabetes Care Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Diabetes Care Drugs Market
9.1.5.1.1 United States Diabetes Care Drugs Market by Product
9.1.5.1.2 United States Diabetes Care Drugs Market by Distribution Channel
9.1.5.2 Canada Diabetes Care Drugs Market
9.1.5.2.1 Canada Diabetes Care Drugs Market by Product
9.1.5.2.2 Canada Diabetes Care Drugs Market by Distribution Channel
9.1.5.3 Mexico Diabetes Care Drugs Market
9.1.5.3.1 Mexico Diabetes Care Drugs Market by Product
9.1.5.3.2 Mexico Diabetes Care Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Diabetes Care Drugs Market Overview
9.2.2 Europe Diabetes Care Drugs Market Forecasts and Analysis
9.2.3 Europe Diabetes Care Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Diabetes Care Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Diabetes Care Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Diabetes Care Drugs Market
9.2.5.1.1 Germany Diabetes Care Drugs Market by Product
9.2.5.1.2 Germany Diabetes Care Drugs Market by Distribution Channel
9.2.5.2 France Diabetes Care Drugs Market
9.2.5.2.1 France Diabetes Care Drugs Market by Product
9.2.5.2.2 France Diabetes Care Drugs Market by Distribution Channel
9.2.5.3 Italy Diabetes Care Drugs Market
9.2.5.3.1 Italy Diabetes Care Drugs Market by Product
9.2.5.3.2 Italy Diabetes Care Drugs Market by Distribution Channel
9.2.5.4 Spain Diabetes Care Drugs Market
9.2.5.4.1 Spain Diabetes Care Drugs Market by Product
9.2.5.4.2 Spain Diabetes Care Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Diabetes Care Drugs Market
9.2.5.5.1 United Kingdom Diabetes Care Drugs Market by Product
9.2.5.5.2 United Kingdom Diabetes Care Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Diabetes Care Drugs Market Overview
9.3.2 Asia-Pacific Diabetes Care Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Diabetes Care Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Diabetes Care Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Diabetes Care Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Diabetes Care Drugs Market
9.3.5.1.1 Australia Diabetes Care Drugs Market by Product
9.3.5.1.2 Australia Diabetes Care Drugs Market by Distribution Channel
9.3.5.2 China Diabetes Care Drugs Market
9.3.5.2.1 China Diabetes Care Drugs Market by Product
9.3.5.2.2 China Diabetes Care Drugs Market by Distribution Channel
9.3.5.3 India Diabetes Care Drugs Market
9.3.5.3.1 India Diabetes Care Drugs Market by Product
9.3.5.3.2 India Diabetes Care Drugs Market by Distribution Channel
9.3.5.4 Japan Diabetes Care Drugs Market
9.3.5.4.1 Japan Diabetes Care Drugs Market by Product
9.3.5.4.2 Japan Diabetes Care Drugs Market by Distribution Channel
9.3.5.5 South Korea Diabetes Care Drugs Market
9.3.5.5.1 South Korea Diabetes Care Drugs Market by Product
9.3.5.5.2 South Korea Diabetes Care Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Diabetes Care Drugs Market Overview
9.4.2 Middle East and Africa Diabetes Care Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Diabetes Care Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Diabetes Care Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Diabetes Care Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Diabetes Care Drugs Market
9.4.5.1.1 South Africa Diabetes Care Drugs Market by Product
9.4.5.1.2 South Africa Diabetes Care Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Diabetes Care Drugs Market
9.4.5.2.1 Saudi Arabia Diabetes Care Drugs Market by Product
9.4.5.2.2 Saudi Arabia Diabetes Care Drugs Market by Distribution Channel
9.4.5.3 U.A.E Diabetes Care Drugs Market
9.4.5.3.1 U.A.E Diabetes Care Drugs Market by Product
9.4.5.3.2 U.A.E Diabetes Care Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Diabetes Care Drugs Market Overview
9.5.2 South and Central America Diabetes Care Drugs Market Forecasts and Analysis
9.5.3 South and Central America Diabetes Care Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Diabetes Care Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Diabetes Care Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Diabetes Care Drugs Market
9.5.5.1.1 Brazil Diabetes Care Drugs Market by Product
9.5.5.1.2 Brazil Diabetes Care Drugs Market by Distribution Channel
9.5.5.2 Argentina Diabetes Care Drugs Market
9.5.5.2.1 Argentina Diabetes Care Drugs Market by Product
9.5.5.2.2 Argentina Diabetes Care Drugs Market by Distribution Channel
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. DIABETES CARE DRUGS MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILLY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JOHNSON AND JOHNSON
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERCK AND CO., INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVO NORDISK
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI S.A.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca plc.
2. Boehringer Ingelheim GmbH
3. Eli Lilly and Company
4. GlaxoSmithKline plc.
5. Johnson & Johnson
6. Merck & Co., Inc.
7. Novartis AG
8. Novo Nordisk
9. Sanofi S.A.
10. Takeda Pharmaceutical Company Limited

TIPRE00008471
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount